Erasca, Inc. Files 8-K on Shareholder Vote Matters
Ticker: ERAS · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1761918
| Field | Detail |
|---|---|
| Company | Erasca, Inc. (ERAS) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
TL;DR
Erasca filed an 8-K for a shareholder vote. Expect news on corporate decisions soon.
AI Summary
On June 24, 2025, Erasca, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing, made on June 26, 2025, pertains to corporate governance and shareholder decisions.
Why It Matters
This filing indicates that Erasca, Inc. is engaging its shareholders in important corporate decisions, which could impact the company's strategic direction and governance.
Risk Assessment
Risk Level: low — This is a routine corporate filing regarding shareholder votes and does not indicate immediate financial distress or significant operational changes.
Key Players & Entities
- Erasca, Inc. (company) — Registrant
- June 24, 2025 (date) — Date of earliest event reported
- June 26, 2025 (date) — Date of report filing
- Delaware (jurisdiction) — State of Incorporation
- San Diego, California (location) — Principal Executive Offices
FAQ
What specific matters are being submitted for a vote of security holders?
The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific matters within the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 24, 2025.
What is the Commission File Number for Erasca, Inc.?
The Commission File Number for Erasca, Inc. is 001-40602.
Where are Erasca, Inc.'s principal executive offices located?
Erasca, Inc.'s principal executive offices are located at 3115 Merryfield Row Suite 300, San Diego, California, 92121.
What is the SIC code for Erasca, Inc.?
The Standard Industrial Classification (SIC) code for Erasca, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding Erasca, Inc. (ERAS).